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Risk Factors for Abdominal Aortic Aneurysms in Smokers 
P. J. Franks*, R. J. Edwards, R. M. Greenhalgh and J. T. Powellt 
Department of Surgery, Charing Cross & Westminster Medical School, Fulham Palace Road, London, W6 8RF, U.K. 
Objective: To investigate features of the smoking habit and other cardiovascular isk factors associated with the 
development ofabdominal aortic aneurysm in smokers. 
Design and setting: Case control study of smokers recruited, between 1989 and 1992, in a London teaching hospital. 
Subjects: Consecutive smokers referred with abdominal aortic aneurysm (cases n = 44) and 244 age and sex-matched 
smokers attending Dermatology, Orthopaedic and Urology clinics (controls). 
Main results: Hypertension was more common amongst he patients with aneurysm (30%) than the controls (19%). 
Measured systolic and diastolic blood pressures were significantly higher in the aneurysm patients. The relative risk of 
having an abdominal aortic aneurysm increased 3.4-fold (95%CI 1.06-10.89) for those with a distolic blood pressure of 
> 90mmHg, p = 0.035 and 4.1-fold (95% CI 1.27-13.16)for those with a mean arterial pressure ~ lOOmmHg, p -- 0.009. 
Plasma lipids, fibrinogen and cotinine were similar amongst patients with aneurysm and controls. The cumulative smoking 
exposure was similar in the patients with aneurysm and controls, median 49 and 44 pack-years respectively. The relative 
risk of developing an aneurysm increased with the number of cigarettes currently smoked, p = 0.008, and with increasing 
depth of inhalation, p = 0.025, but was not associated with the tar or nicotine yield of current cigarettes. 
Conclusions: In smokers, the risk of developing an abdominal aortic aneurysm increases with increasing mean arterial and 
diastol& blood pressure and two aspects of current smoking habit: the number of cigarettes currently smoked and the depth 
of inhalation. 
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Introduction 
Abdominal aortic aneurysm (AAA) is a common 
disorder in the ageing population. Most of those who 
develop an AAA have been heavy smokers. The first 
clear association between smoking and abdominal 
aortic aneurysm was provided by the Framingham 
StudyJ More recently the Whitehall Study has indi- 
cated that the risk of death from AAA increases 4-fold 
for smokers as compared with non-smokers and the 
risk of death from AAA increased 14-fold for those 
who had smoked hand rolled cigarettes. 2 Therefore, 
there may be particular aspects of the smoking habit 
which predispose to aneurysmal dilatation and rup- 
ture of the aorta in later life. However, not all smokers 
develop an AAA and smoking must interact with 
other environmental nd genetic factors to potentiate 
aortic dilatation. There is a strong familial tendency to 
AAA, with about 25% of the brothers of patients with 
aneurysm having an aneurysm detected on ultra- 
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sound screening. 3"4 In the Honolulu Heart Program, 
high blood pressure, high concentrations of serum 
cholesterol and height were identified as predictors of 
AAA, although pack-years of cigarette smoking 
remained the strongest predictor of AAA. s 
In order to confirm some of these cofactors of 
smoking as predictors of AAA, we have compared the 
smoking habits and other cardiovascular risk factors 
in smokers with and without clinical AAA. 
Subjects and Methods 
Cases comprised consecutive new referrals, 
1989-1992, to the Vascular Surgical Service at Charing 
Cross Hospital for AAA, who reported smoking in the 
previous 4weeks (current smokers). The patients with 
AAA (cases) comprised 37 men and seven women, 
median age 69.8 years. The anterior posterior diameter 
of the aneurysm varied from 5.4-9.8cm and all were 
detected by clinical examination. By means of system- 
atic screening of suitable clinics and wards over the 
same period, 961 potential controls who also reported 
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smoking in the previous 4 weeks, were identified, of 
whom 899 agreed to take part in the study. Of these, 
556 (62%) were recruited from outpatient clinics 
(orthopaedic, dermatology and urology) at Charing 
Cross and St Mary's Hospitals and 343 (38%) from 
Charing Cross inpatient wards (short sta)~ urolog~ 
general surgery and orthopaedic). A standard ques- 
tionnaire was either completely administered or 
where this was impossible, partly administered and 
then taken away to be completed at home and 
returned by post. Twenty-two cases and 39 controls 
failed to return their questionnaires and did not 
respond to further enquiries. 
Cases and controls reporting a history of emphy- 
sema or of cancer of the lung, upper respiratory tract, 
mouth, lip, stomach, oesophagus or bladder were 
excluded. History or palpation of an AAA also was an 
exclusion criterion. Following application of these 
exclusion criteria the 44 cases and 779 controls (495 
males) remained eligible for inclusion in the study. 
From this population of control subjects up to five or 
six matched controls were selected for each case, by 
manually finding same sex and ethnic group controls 
whose age was closest o the control to a maximum 
difference of + 2 years. This resulted in 244 controls 
being selected. 
Both cases and controls had been administered a 
questionnaire. Past history of diabetes, high blood 
pressure and abnormal blood fats with details of 
current medication and a history of parents or siblings 
dying from cardiovascular disease before the age of 60 
were recorded in the questionnaire. Social class was 
assessed on the basis of current and past employ- 
ment. 6Spouse's occupation was used for married or 
widowed female subjects, and the subject's last occu- 
pation was used if currently retired or unemployed. 
Ethnic origin was recorded as White, Black, Asian, 
other or unknown. For each mode of tobacco use 
(manufactured cigarettes, roll-ups, pipes and cigars) 
subjects were asked for the age at which they started 
smoking, whether they had stopped and when and 
maximum amounts smoked per day between ages 
15-30, 31-50, 51 and above and during the last year. 
Roll-up cigarette smokers were asked to give amounts 
smoked per day as either number of cigarettes smoked 
per day or ounces of tobacco. The latter quantity was 
converted to number of cigarettes moked per day 
using 0.5 ounces of tobacco as equivalent o 20 
cigarettes. Pack years were calculated for manu- 
factured and roll-up cigarette smokers by multiplying 
duration of smoking by the number of cigarettes 
smoked per day divided by 20, for the three age 
bands, and these values were then added together. 
Manufactured cigarette smokers were asked for the 
length of time they had smoked filter tipped cigarettes 
and roll-up cigarette smokers, whether they inserted 
filters into their roll-ups. Manufactured cigarette 
smokers were asked for the exact names of the brands 
they had smoked in the previous 5 years and for how 
long they had smoked each. Average yields of tar, 
carbon monoxide and nicotine per cigarette were 
coded from estimates given by the Laboratory of the 
Government Chemist for June 1989. Newer brands 
were coded according to later estimates. Cigarette 
smokers were asked for usual length of cigarette 
smoked (greater than half, about half or less than half) 
and usual depth of inhalation (mouth and nose onl)~ 
back of throat, lungs moderately or lungs deeply). All 
subjects were asked how many times they had 
smoked in the previous day and on the day of their 
interview. 
Subjects identified which of four ascending cate- 
gories of daily physical activity reflected their normal  
lifestyle: usually sitting down; standing or walking 
about quite a lot but not lifting much; usually lifting or 
carrying light loads and climbing stairs or hills; doing 
heavy work. The last category accounted for only a 
small number of subjects and was therefore combined 
with the third category in the analyses. Specific dietary 
questions concerning use of alcohol, regularity of 
meals, salt intake, and weekly average consumption of
cheese, eggs, fried food and fish were recorded, using 
a validated questionnaire. 7 
Height, weight, blood pressure readings and perti- 
nent findings of clinical examination of the abdomen 
were recorded. Mean arterial pressure was calculated 
as diastolic pressure + one-third pulse pressure. Non- 
fasting blood samples were obtained by antecubital 
venepuncture using EDTA anticoagulated tubes. Car- 
boxyhaemoglobin was measured on an 1L-282 car- 
boximeter, plasma thiocyanate by an automated col- 
ourmetric assay s and plasma cotinine by gas liquid 
chromatography. 9 Total cholesterol, fibrinogen and 
apolipoprotein (B) were measured as previously 
described. 1° Apolipoprotein (a) was measured by 
radioimmunoassay (Pharmacia UK) according to the 
manufacturer's instructions. 
Statistical methods 
Unmatched analysis was by Mann Whitney U-test. 
Matched analyses were carried out by conditional 
logistic regression using the STATA statistical package. 
To assess the strength of association between each 
variable and the disease, odds ratios with 95% 
confidence intervals were calculated. Continuous vari- 
Eur J Vasc Endovasc Surg Vo111, May 1996 
Abdominal Aortic Aneurysms in Smokers 480 
ables were categorised into tertiles. Statistical sig- 
nificance was assumed when p < 0.05. 
Results 
The general characteristics of smokers with clinical 
AAA (cases) and smokers without clinical AAA 
(controls) are shown in Table 1: all were of white 
ethnic origin. The unmatched analysis immediately 
indicates that blood pressure is a factor which distin- 
guishes cases from controls. Moreover the mean 
arterial pressure was calculated to be significantly 
higher in cases compared with controls, median 112 
(IQR 100-117) mmHg in the cases, compared with 98 
(IQR 88-107) mmHg in controls, p--0.007. Diabetes 
was more common amongst the controls than the 
cases. 
Matched analysis of selected potential risk factors 
for AAA in cases and controls is shown in Table 2. The 
risk of having a clinical AAA was associated with 
hypertension and several aspects of the smoking 
habit. The tendency for the risk of having a clinical 
AAA to be associated inversely with both plasma 
cholesterol concentrations and physical activity failed 
to achieve statistical significance (Table 2). The risk of 
clinical AAA was not associated with height, body 
mass index, social class, family history of premature 
cardiovascular disease, alcohol usage, pattern or type 
of food intake, plasma fibrinogen, apolipoprotein B or 
lipoprotein (a) concentration. 
A history of hypertension was reported more often 
by the cases (30%) than the controls (19%), but on 
matched analysis this failed to achieve statistical 
significance, p = 0.124. Cases had significantly higher 
measured blood pressures than the controls (Table 1). 
Matched analysis showed that the risk of having a 
clinical AAA increased, over 3-fold if the diastolic 
pressure was > 90 mmHg, p = 0.035 and over 4-fold 
if the mean arterial pressure was > 100 mmHg, 
p = 0.009. The 2 to 3-fold increased the risk if the 
systolic pressure was > 160 mmHg did not achieve 
statistical significance. 
The tendency for patients with clinical AAA to have 
a longer pack-year history of smoking than the 
controls did not achieve statistical significance, 
p = 0.174. However there were significant associations 
between the number of cigarettes currently smoked 
(p = 0.008) and the depth of inhalation (p = 0.025) and 
the risk of clinical AAA. This risk increases 2 to 3-fold 
for those who continue to smoke > 10 cigarettes/day, 
2 to 3-fold for those who inhale moderately into the 
lungs and almost 4-fold for those who inhale deeply 
into the lungs (Table 2). In contrast, there was no 
association between the risk of clinical AAA and either 
the type of tobacco usage (pipe, cigar, cigarette), the 
tar or nicotine yield of cigarette currently smoked, the 
plasma cotinine concentration, or any other blood 
marker of smoking. 
Table 1. Characteristics of patients with AAA and controls 
Cases with AAA Controls 
(n=44) (n=244) *p 
Age (years) 69.8 (64.9-75.4) 70.5 (64.8-75.4) 0.902 
Males (%) 37 (84%) 202 (83%) 1.000 
Height (cm) 173 (167-179) 172 (168-177) 0.357 
BMI (Kg/m 2) 22.8 (21.2-25.4) 23.8 (21.7-26.5) 0.272 
Diabetes (%) 1 (2%) 17 (7%) 0.400 
Tobacco usage at interview: 
Cigarette 42 228 0.866 
Cigar/pipe 2 16 
Tobacco exposure: 
Current (cigs/day) 15 (8-20) 15 (11-20) 0.281 
Total (pack years) 49 (38-72) 44 (30-61) 0.163 
Systolic pressure 156 (131-171) 137 (123-151) 0.005 
(mmHg) 
Diastolic pressure 87 (74-95) 80 (71-89) 0.026 
(mmHg) 
Cholesterol (mmol/1) 5.2 (4.2-6.0) 5.5 (4.7-6.3) 0.178 
Apolioprotein B (g/l) 0.73 (0.60~).86) 0.72 (0.62-0.93) 0.966 
Lp (a) mg/dl 21.0 (11.7-35.5) 20.8 (7.35-58.8) 0.928 
Fibrinogen (g/l) 5.65 (4.81-6.68) 5.40 (4.78-6.31) 0.571 
Cotinine (nmol/1) 392 (185-853) 408 (198-759) 0.424 
*Unmatched analysis by Mann Whitney U-test or chi-squared (sex, 
tobacco usage, diabetes). The results for continuous variables are 
given as median (interquartile range). 
Discussion 
The apparent increase in the incidence of abdominal 
aortic aneurysm during the last 25 years comes many 
years (30-40) after the popularization of cigarette 
smoking in Britain. n'12 There appears to be a 40 year 
lag interval between the increase in cigarette con- 
sumption and the increasing incidence of abdominal 
aortic aneurysm (Fig. 1). An association between a 
long history of smoking and an increased risk of 
abdominal aortic aneurysm would be in keeping with 
5 the findings in the Honolulu Heart Program. In our 
study the tendency for the risk of clinical AAA to 
increase when the cumulative smoking exposure 
exceeded 35 pack-years did not achieve statistical 
significance, but other features of the smoking habit 
were associated more closely with an increased risk of 
clinical AAA. 
Our study was designed to illuminate whether 
specific aspects of the smoking habit increased the risk 
of abdominal aortic aneurysm; hence the study design 
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comparing smokers with clinical AAA and smokers 
with no clinical evidence of AAA. Whilst physical 
examination readily detects large AAA the sensitivity 
of physical examination for small ( < 5cm in diameter) 
or sub-clinical AAA is poor. 13 Since the controls were 
not screened for AAA using ultrasonography, which is 
both sensitive and specific, we cannot exclude the 
possibility that some of the controls may have had 
sub-clinical aneurysms. Therefore, our findings are 
pertinent only to factors associated with the develop- 
ment of large, or clinical, AAA in smokers. 
Two particular aspects of the smoking habit appear 
to significantly increase the risk of developing a large 
AAA: the current cigarette consumption and the 
depth of inhalation. The continued absorption of 
chemicals from the deep inhalation of many cigarettes 
may act directly to potentiate aneurysmal dilatation or 
indirectly through effects on proteolytic, fibrinolytic 
mechanisms and smooth muscle metabolism. 14-17 This 
would accord with recent indications that the growth 
rate of small aneurysms i faster in smokers than non- 
smokers. 18 The lack of association between either the 
tar or nicotine yield of the current cigarette or plasma 
cotinine (a long lived metabolite of nicotine) and risk 
of clinical AAA might indicate that such growth 
promoting chemicals are not derived from either tar or 
nicotine. However, since the tar and nicotine yield of 
cigarettes used may have changed rapidly over the 
previous years, current yields may provide a poor 
indicator of previous habits. 
This study also has confirmed the increased risk of 
clinical AAA in the presence of hypertension, as 
observed in other studies. 2'5 In the Honolulu Heart 
Program, in men of Japanese ancestry, systolic hyper- 
tension was a much stronger isk factor for AAA than 
diastolic hypertension. 5 In contrast, in the Whitehall 
Stud35 of British civil servants, the risk of death from 
AAA was associated with diastolic hypertension. 2 Our 
British study also indicates that diastolic hyper- 
tension, which was associated with a 3 to 4-fold 
Table 2. Matched analysis for smoking habits and cardiovascular risk factors 
Risk of having AAA 
Odds ratio 95% CI p* 
Diabetes No 1.00 
Yes 0.33 
History of hypertension No 1.00 
Yes 1.87 
Systolic pressure (mmHg) <160 1.0 
>160 2.26 
Diastolic pressure (mmHg) <90 1.0 
>90 3.37 
Mean arterial pressure (mmHg) <100 1.0 
>100 4.08 
Smoking/history (pack years) <35 1.0 
35-55 2.07 
>56 1.84 
Current smoking (cigarettes/day) 0-10 1.0 
11-20 3.03 
>21 1.99 
Inhalation Mouth 1.0 
Throat 1.0 
Lungs mod 2.55 
Lungs deep 3.93 
Tar, yield current cigarette (rag) 0-8 1.0 
9-13 1.04 
>14 0.62 
Cotinine plasma concentration ( mol/1) <225 1.0 
225~09 0.54 
>610 0.82 
Alcohol (units /week) 0 1.0 
0-9 0.67 
>10 1.09 
Activity: Sedentary 1.0 
Moderate 0.58 
Active 0.29 
Plasma cholesterol (mmol/1) <5.0 1.0 
5.0~.0 0.52 
>6.0 0.36 
(0.04-2.61) 
(0.84-4.16) 
(0.77-6.66) 
(1.06-10.89) 
(1.27-13.16) 
(0.954.52) 
(0.61-3.42) 
(1.29-7.22) 
(0.77-3.73) 
(0.26-3.90) 
(0.88-7.15) 
(1.33-12.16) 
(0.38-2.85) 
(0.2_A--1.59) 
(0.18-1.58) 
(0.26-2.57) 
(0.27-1.68) 
(0.51-2.31) 
(0.28-1.21) 
(0.07-1.16) 
(0.17-1.60) 
(0.12-1.09) 
0.206 
0.124 
0.131 
0.035 
0.009 
0.174 
0.008 
0.025 
0.495 
0.509 
0.554 
0.104 
0.166 
*from Chi-squared test. 
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Fig. 1. Cigarette consumption and mortality from abdominal aortic aneurysm. There is a lag interval of about 40 years between increasing 
consumption of cigarettes and increasing mortality from abdominal aortic aneurysm in England and Wales. Data for cigarette consumption 
are from the UK Tobacco Advisory Council and the age-standardised mortality figures are taken from Fowkes et al. ~ 
increase in risk of developing a clinical AAA in 
smokers, is a stronger risk factor for AAA than systolic 
hypertension. However the prevailing distending 
pressure on the aorta, mean arterial pressure, appears 
to be even more significantly associated with the risk 
of developing a clinical AAA. In contrast with the 
findings in the Honolulu Heart Program, in our study 
there was no increased risk associated with increased 
plasma cholesterol concentration. Rather there was a 
tendency for the risk of clinical AAA to decrease with 
increasing cholesterol concentration. Exercise often 
has been associated with improved cardiovascular 
fitness. In this respect AAA may be no different from 
other cardiovascular disorders, since there was a 
tendency for the risk of clinical AAA to decrease in 
association with a more active lifestyle. 
In summary, this small study has provided insight 
into particular aspects of smoking associated with the 
development of large aneurysms. The heavy, deeply 
inhaling smokers are at highest risk. Mean arterial 
pressure, together with diastolic hypertension, appear 
to be important factors for the development of large 
AAA in smokers. If this is true, we anticipate that the 
declining popularity of smoking, together with 
improved treatment of hypertension, will result a 
decline in the incidence of AAA in the 21st Century. 
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